Category: Clinical Trial Update Region: Asia · Taiwan, Province of China Company: Syneurx International Taiwan Corporation

Syneurx Announces Final Results Of Phase 2 Clinical Trial Of Covid 19 Oral Antiviral Candidate Pentarlandir

Syneurx Announces Final Results Of Phase 2 Clinical Trial Of Covid 19 Oral Antiviral Candidate Pentarlandir
Syneurx

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!